CD86 and breast cancer: Likewise, co-culturing BRCA1-mutant breast cancer MDA-MB-436 cells with human THP-1 macrophages showed that MDA-MB-436 cells significantly increased M2-like polarization of THP-1, as shown by up-regulation of CD163 (an M2 marker) and reduction of CD86 (an M1 marker), which was not significantly affected by olaparib (Supplementary Fig. 2c).